Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Leite

Showing results (131-140 of 190) with videos related to

Pageof 19
Sort By:
Annals of the New York Academy of Sciences|January 30, 2018
Serological and experimental studies in different forms of myasthenia gravisAngela Vincent, Saif Huda, Michelangelo Cao, et al.
Brain : a Journal of Neurology|April 3, 2019
Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disordersJacqueline Palace, Dan-Yu Lin, Donglin Zeng, et al.
Multiple Sclerosis and Related Disorders|February 4, 2021
The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple SclerosisSilvia Messina, Romina Mariano, Ruth Geraldes, et al.
Neuromuscular Disorders : NMD|January 7, 2018
MuSK myasthenia gravis and pregnancyErnestina Santos, Antonio Braga, Denis Gabriel, et al.
Multiple Sclerosis and Related Disorders|December 17, 2018
Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesionsMaureen A Mealy, Sarah E Mossburg, Su-Hyun Kim, et al.
Brain : a Journal of Neurology|June 22, 2014
Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomesAlexander Carvajal-González, M Isabel Leite, Patrick Waters, et al.
European Journal of Neurology|February 6, 2021
Foveal changes in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder are independent of optic neuritis and not overtly progressiveAdriana Roca-Fernández, Frederike Cosima Oertel, Tianrong Yeo, et al.
Journal of Neurochemistry|February 23, 2026
CASPR2 Autoimmune Antibodies Induce Neuronal Hyperactivity in Human Brain OrganoidsAna Rafaela Oliveira, Giuseppe Cammarata, Catarina Seabra, et al.
Frontiers in Neurology|July 17, 2020
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence WorldwideJyh Yung Hor, Nasrin Asgari, Ichiro Nakashima, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 21, 2018
Retinal ganglion cell loss in neuromyelitis optica: a longitudinal studyFrederike C Oertel, Joachim Havla, Adriana Roca-Fernández, et al.
Pageof 19

Showing results (131-140 of 190) with videos related to

Sort By:
Pageof 19
Annals of the New York Academy of Sciences|January 30, 2018
Serological and experimental studies in different forms of myasthenia gravisAngela Vincent, Saif Huda, Michelangelo Cao, et al.
Brain : a Journal of Neurology|April 3, 2019
Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disordersJacqueline Palace, Dan-Yu Lin, Donglin Zeng, et al.
Multiple Sclerosis and Related Disorders|February 4, 2021
The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple SclerosisSilvia Messina, Romina Mariano, Ruth Geraldes, et al.
Neuromuscular Disorders : NMD|January 7, 2018
MuSK myasthenia gravis and pregnancyErnestina Santos, Antonio Braga, Denis Gabriel, et al.
Multiple Sclerosis and Related Disorders|December 17, 2018
Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesionsMaureen A Mealy, Sarah E Mossburg, Su-Hyun Kim, et al.
Brain : a Journal of Neurology|June 22, 2014
Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomesAlexander Carvajal-González, M Isabel Leite, Patrick Waters, et al.
European Journal of Neurology|February 6, 2021
Foveal changes in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder are independent of optic neuritis and not overtly progressiveAdriana Roca-Fernández, Frederike Cosima Oertel, Tianrong Yeo, et al.
Journal of Neurochemistry|February 23, 2026
CASPR2 Autoimmune Antibodies Induce Neuronal Hyperactivity in Human Brain OrganoidsAna Rafaela Oliveira, Giuseppe Cammarata, Catarina Seabra, et al.
Frontiers in Neurology|July 17, 2020
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence WorldwideJyh Yung Hor, Nasrin Asgari, Ichiro Nakashima, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 21, 2018
Retinal ganglion cell loss in neuromyelitis optica: a longitudinal studyFrederike C Oertel, Joachim Havla, Adriana Roca-Fernández, et al.
Pageof 19